| Name |
Surname |
Abstract Title |
| Darrell |
Abernethy |
Effects of New Drugs in Older Patients: What is Known at the Time of Drug Approval |
| Mansoor |
Ahmed |
Radiation-induced TGF-β signaling: Opportunities for sensitization and protection |
| Stephen |
Alexander |
Role of cannabinoid-related receptors (GPR55, GPR18 and GPR119) in inflammation, satiety and obesity |
| Adriana |
Andrade |
Interactions between antiretrovirals and complementary medicines |
| Stephen |
Ansell |
Antibody-drug conjugates (ADCs) in lymphoma |
| Scott |
Armstrong |
Click Here For Presentation |
| Jamil |
Assreuy |
Triggering cell activation in sepsis vascular dysfunction |
| Stephen |
Ayinbuomwan |
Safety and tolerability profile of artemisinin-based antimalarial combination therapy (ACT) in adult Nigerians |
| Dinesh Kumar |
Badyal |
Click Here For Presentation |
| Richard |
Barker |
Engaging the public and policy community about advances in personalized medicines |
| Joey |
Barnett |
Do we need international Standards: US position |
| Jeff |
Barrett |
The Drug Dashboard – integrating medical informatics with dosing decisions. |
| Chas |
Bountra |
The Structural Genomics Consortium as a springboard for discovery in epigenetics and kinases |
| Alison |
Bowers |
The Changing Regulatory Environment of Pediatric Drug Development. |
| Adrian |
Brink |
The Global spread of multi-drug resistant Gram negative bacteria |
| Tiaan |
Brink |
Do we need international Standards: South African position |
| Kay |
Brune |
OTC Analgesics: abuse in endurance sports |
| Christopher |
Butler |
Limiting the use of antibiotics in primary care |
| Ingolf |
Cascorbi |
Click Here For Presentation |
| William |
Catterall |
Click Here For Presentation |
| Kin-Wei Arnold |
Chan |
Click Here For Presentation |
| Fernando |
Civeira |
Drug targets for lipid modyfying strategies |
| Stuart |
Conway |
Targeting epigenetic readers in inflammation and cancer |
| Leticia |
Costa-lotufo |
Anticancer compounds from marine microorganisms collected at Brazilian tropical seas |
| Patrick |
Couvreur |
Nanomedicine for the Treatment and Diagnostic of Severe Diseases |
| Tim |
Cressey |
Development of a HIV Clinical Pharmacology Program within a Maternal & Pediatric HIV prevention and treatment program in Thailand |
| Fernando |
Cunha |
Failure of neutrophil migration and the pathogenesis of sepsis |
| Nicola |
Curtin |
PARP and CHK inhibitors as anticancer therapeutics |
| Yara |
Cury |
Molecular mechanisms involved in antinociception induced by crotalphine, peptide from Crotalus venom |
| Dana |
Dabelea |
Developmental Origins of Pediatric Obesity-Challenges and Opportunities |
| Jan |
Danser |
Blockade of prorenin, renin and the (pro)renin receptor: too much of a good thing? |
| Elizabeth |
Davis |
Influences on the uptake of technology for teaching and assessment of pharmacology? Can IUPHAR help? |
| James |
Dear |
Developing Novel Biomarkers for Drug Induced Liver Injury |
| David |
Dewhurst |
Pharmacology teaching, learning and assessment in the 'e-space' - strategies and implementation |
| Michael |
Didie |
Innovative cell therapeutcs and disease models by epigenetic reprogramming |
| Robin |
DiFrancesco |
Global Clinical Pharmacology Quality Assurance & Quality Control Program |
| Kelly |
Dooley |
Emerging antituberculosis agents: Bedaquiline, Delamanid, PA824 |
| Guan hua |
Du |
Exploration for discovery of anti-ischemic stroke drugs targeting the neurovascular unit based on mu |
| Jerome |
Engel |
Use of biomarkers and surrogate endpoints. |
| Fatai |
Fehintola |
Ibadan University Clinical Pharmacology Program |
| Yuansheng |
Gao |
Endothelium-dependent hypoxic contractions : involvement of cyclic IMP |
| Anwar |
Gilani |
Click Here for presentation |
| Brian |
Godman |
Click Here For Presentation |
| Kavita |
Gulati |
Involvement of nitric oxide in the toxicodynamics of drugs and xenobiotics |
| Mary |
Gulumian |
Nanotoxicology and Nanomedicine |
| Tawanda |
Gumbo |
Optimising drug combinations and doses |
| Brian |
Harvey |
Behavioural and biological validation of an animal model of obsessive-compulsive disorder (OCD) |
| Brian |
Harvey |
Methylene blue: New light through old windows |
| Suzanne |
Hill |
High cost challenges: paying for targeted therapies |
| Sarah |
Hilmer |
Multiple Comorbid Conditions and Disease-based Treatment Guidelines: The Therapeutic Dilemma for Older Persons with Geriatric Syndromes |
| Nick |
Holford |
Click Here For Presentation |
| Sam |
Holford |
Nextdose – a web based collaborative tool for target concentration intervention |
| Kalle |
Hoppu |
Children’s access to medicines - Therapeutic orphans being adopted? |
| Kalle |
Hoppu |
GRIP – Global research in paediatrics |
| Kalle |
Hoppu |
GRIP Roadshow and Training modules available in the VLE – training opportunities for where you are |
| Angela |
Ianaro |
Is COX a potential target in human melanoma? |
| Gaetano |
Iaquinto |
The clinical reality of preventing & treating gastroduodenal ulcers |
| Muazzam |
Jacobs |
TNFRp75 mediated inflammation and immune regulation during pulmonary tuberculosis |
| Branislav |
Jeremic |
Irradiation and drugs |
| David |
Juurlink |
Using Pharmacovigilance to Identify Serious Adverse Drug Reactions |
| Gregory |
Kearns |
Developmental pharmacology in infants and children |
| Hideo |
Kimura |
The pharmacology of H2S |
| Yajna |
Kooblal |
UNLICENSED AND OFF LABEL DRUG USE IN HIGHLY SPECIALISED PAEDIATRIC WARDS |
| Ismael |
Laher |
Improving endothelial function in type 2 diabetes |
| David |
Le Couteur |
Deprescribing to Limit Polypharmacy: The Evidence Base |
| Carel |
Le Roux |
How the gut talks to the brain: lessons for new anti obesity drugs |
| Steven |
Leeder |
The view from North-America |
| Gian Marco |
Leggio |
Dopamine D3 receptors and alcohol addiction |
| James |
Lewis |
Introduction to drug-induced liver injury: types, mechanisms, salient characteristics. |
| Lenard |
Lichtenberger |
Role of platelets and Aspirin-PC in Cancer |
| Lenard |
Lichtenberger |
Development of new, safe NSAIDs |
| Thomas |
MacDonald |
Streamline Randomised Comparative Effectiveness |
| Chantal Beatrice |
Magne Nde |
Timeless, a novel oestrogen receptor co-activator with a critical role in breast cancer |
| Janet |
Maguire |
From aids to atherosclerosis: chemokines, CCR5 and maraviroc |
| Collen |
Masimirembwa |
The view from Africa |
| Alejandro |
Mayer |
Click Here For Presentation |
| Marc |
Mendelson |
Limiting use of antibiotics in hospitals |
| John |
Miners |
In vitro characterisation of the inhibition of drug metabolising enzymes |
| Shirra |
Moch |
Flipping the classroom: Using technology to build core learning structures in clinical pharmacology |
| Gene |
Morse |
New Fogarty HIV Research Training Programs for Capacity Building |
| Tinashe |
Mudzviti |
Hair as a Biomatrix for HIV and TB Clinical Pharmacology Research |
| Michael |
Mulvany |
ORPHEUS-AMSE- WFME Standards for PhD education |
| Claire |
Newton |
Functional Rescue of Inactivating Human LH Receptor Mutants with an Allosteric Agonist |
| Tim |
Noakes |
Evolution and running |
| Carolina |
Nör |
IL-6R blockade as a therapeutic approach to overcome cisplatin resistance in head and neck cancer |
| Vural |
Ozdemir |
Bioethics of Pharnacogenetics |
| George |
Osanjo |
Click Here For Presentation |
| Ellen |
Ovenden |
Investigating functionally significant genome-wide variants associated with antipsychotic treatment response |
| Deepesh |
Pandey |
Activation Of Histone Deacetylase 2: A Novel Strategy For Reversing Vascular Dysfunction In Atherogenesis. |
| Animesh |
Pardanani |
Targeting JAK2 and ABL in myeloid malignancies |
| Richard |
Paules |
Click Here For Presentation |
| Adam |
Pawson |
Orphan G protein-coupled receptors: an update |
| Adam |
Pawson |
IUPHAR-DB, GRAC and the Guidetopharmacology |
| Concha |
Peiro |
Adipokines and cardiometabolic complications |
| Asla |
Pitkanen |
Development of anti-epileptogenic therapies |
| Yves |
Pommier |
Drugging Topoisomerases: Lessons and Challenges |
| Maurizio |
Popoli |
The impact of stress on glutamate transmission and neuronal architecture. A key to pathophysiology and treatment of mood and anxiety disorders |
| Manel |
Puig-domingo |
Cardiovascular benefits of GLP-1 based treatments for diabetes mellitus: hopes or realities |
| Kim |
Rainsford |
Leggio |
| Laurie |
Rauch |
Synchrony between the neocortex and the hypothalamus-brainstem: what can modern diseases learn from sport? |
| Katharine |
Richardson |
Raising the Profile of Pharmacology Through Public Engagement |
| Andrew |
Roberts |
Survival Signals - Targeting the gatekeepers of apoptosis: Inhibition of BCL2 as an approach to therapy |
| Frans |
Russel |
Role of drug transporters in drug exposure and safety |
| Ed |
Rybicki |
Plant-made vaccines: hope emerging from the hype |
| Valeria |
Sandrim |
45G>T polymorphism of ADIPOQ affect the responsiveness to antihypertensive therapy in preeclampsia but not in gestational hypertension |
| Adalberto |
Santos |
Pharmacogenetics and safety of antituberculosis drugs. |
| Antonio |
Sarikas |
Pe(E)r-Learning: the potential of peer-teaching to create high quality e-Learning content. |
| Georg |
Schett |
PDE4 inhibitors in the treatment of arthritis and psoriasis |
| Tabassome |
Simon |
Clinical development strategies: from primary prevention to orphan indications |
| Anthony J |
Smith |
Regulatory approaches to herbal and traditional medicines and the role of education |
| Marvin A |
Soriano-Ursua |
Click Here For Presentation |
| Shalini |
Sri Ranganathan |
Drug safety in children |
| William |
Stoops |
Human Laboratory Evaluation of Putative Combination Pharmacotherapies for Stimulant Use Disorders |
| Edward |
Sturrock |
Novel domain-selective ACE inhibitors: antihypertensives or antifibrotics? |
| Roger |
Summers |
Click Here For Presentation |
| John |
Szarek |
Question writing for any occasion: Use of questions in assessment and learning. |
| Koji |
Takeuchi |
Prophylactic Effects of Prostaglandin E2 on NSAID-Induced Enteropathy: Role of EP4 Receptors in Its Protective and Healing-Promoting Effects |
| Sripen |
Tantivess |
Health and economic impact of government use licenses for essential medicines in Thailand |
| Peter |
Taylor |
New ways to treat bacterial infections. |
| Mauro |
Teixeira |
Systemic inflammatory response syndrome in viral and infections |
| Teresa |
Tejerina |
Diabetes Mellitus and Vascular Inflammation Old And New Models For Translational Research |
| Angela |
Timoney |
The national Scottish partnership model of rapid HTA of new medicines: 10 years experience |
| Jean-françois |
Toussaint |
Does sport reveal the end of a long range physiological evolution ? |
| Geoffrey |
Tucker |
Complex drug-drug interactions involving enzymes and transporters - Prediction using physiologically-based pharmacokinetic modelling |
| Jack |
Uetrecht |
Characterization of mechanisms of drug-induced immune mediated liver injury. |
| Wim |
van den Berg |
Deciphering new targets for drug development in chronic arthritis |
| Heikki |
Vapaatalo |
Phosphodiesterase 4 inhibitors as anti-inflammatory drugs |
| Felix |
Viana |
TRPA1 CHANNELS ARE NEURONAL SENSORS OF BACTERIAL ENDOTOXINS |
| Xiaoliang |
Wang |
Dl-PHPB, a novel drug candidate for Alzheimer's disease |
| Adrian |
Wiestner |
Click Here For Presentation |
| Thomas |
Witzig |
Targeting the mTOR pathway in hematological malignancies |
| Lonnie |
Wollmuth |
Outer Structures in Ionotropic Glutamate Receptors as Drug Targets |
| Wai Shiu Fred |
Wong |
Development of anti-malarial drug artesunate as an anti- inflammatory agent for allergic asthma and COPD |
| Clive |
Zent |
Unconjugated mAb therapy in B cell malignancies |
